Stay updated on Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added revision entry v3.5.2 and removed v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:01.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the Record History and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    - The history now shows Revision: v3.4.3, replacing the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:28.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior funding-status notice (v3.4.1).
    Difference
    0.5%
    Check dated 2026-02-11T14:01:57.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Two minor changes are shown: a site-wide notice about government funding status and a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:11:33.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Adds a glossary toggle, color-coded additions/deletions, and a revision label, and removes the older No FEAR Act data line.
    Difference
    0.6%
    Check dated 2026-01-28T05:45:19.000Z thumbnail image

Stay in the know with updates to Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.